NF-κB and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC.
NF-κB and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC.
复制标题
NF-κB 和 pSTAT3 协同驱动 G6PD 过度表达并促进 ccRCC 中对 G6PD 抑制的敏感性
DOI:
10.1186/s12935-020-01576-2
复制
发表时间:
2020
影响因子:
5.8
通讯作者:
Zhu Y
中科院分区:
文献类型:
--
作者:
Zhang Q;Yang Z;Ni Y;Bai H;Han Q;Yi Z;Yi X;Agbana YL;Kuang Y;Zhu Y
BackgroundGlucose 6-phosphate dehydrogenase (G6PD) serves key roles in cancer cell metabolic reprogramming, and has been reported to be involved in certain carcinogenesis. Previous results from our laboratory demonstrated that overexpressed G6PD was a potential prognostic biomarker in clear cell renal cell carcinoma (ccRCC), the most common subtype of kidney cancer. G6PD could stimulate ccRCC growth and invasion through facilitating reactive oxygen species (ROS)-phosphorylated signal transducer and activator of transcription 3 (pSTAT3) activation and ROS-MAPK-MMP2 axis pathway, respectively. However, the reasons for ectopic G6PD overexpression and the proliferation repressive effect of G6PD inhibition in ccRCC are still unclear.MethodsThe impact of ROS accumulation on NF-κB signaling pathway and G6PD expression was determined by real-time RT-PCR and Western blot in ccRCC cells following treatment with ROS stimulator or scavenger. The regulatory function of NF-κB signaling pathway in G6PD transcription was analyzed by real-time RT-PCR, Western blot, luciferase and ChIP assay in ccRCC cells following treatment with NF-κB signaling activator/inhibitor or lentivirus infection. ChIP and Co-IP assay was performed to demonstrate protein-DNA and protein–protein interaction of NF-κB and pSTAT3, respectively. MTS assay, human tissue detection and xenograft model were conducted to characterize the association between NF-κB, pSTAT3, G6PD expression level and proliferation functions.ResultsROS-stimulated NF-κB and pSTAT3 signaling over-activation could activate each other, and exhibit cross-talks in G6PD aberrant transcriptional regulation. The underlying mechanism was that NF-κB signaling pathway facilitated G6PD transcription via direct DNA–protein interaction with p65 instead of p50. p65 and pSTAT3 formed a p65/pSTAT3 complex, occupied the pSTAT3-binding site on G6PD promoter, and contributed to ccRCC proliferation following facilitated G6PD overexpression. G6PD, pSTAT3, and p65 were highly expressed and positively correlated with each other in ccRCC tissues, confirming that NF-κB and pSTAT3 synergistically promote G6PD overexpression. Moreover, G6PD inhibitor exhibited tumor-suppressor activities in ccRCC and attenuated the growth of ccRCC cells both in vitro and in vivo.ConclusionROS-stimulated aberrations of NF-κB and pSTAT3 signaling pathway synergistically drive G6PD transcription through forming a p65/pSTAT3 complex. Moreover, G6PD activity inhibition may be a promising therapeutic strategy for ccRCC treatment.
登录
查看更多内容
DOI:
10.1038/nrurol.2010.47
发表时间:
2010-05
期刊:
Nature reviews. Urology
影响因子:
--
作者:
通讯作者:
--
影响因子:
--
作者:
Fan TF;Wu TF;Bu LL;Ma SR;Li YC;Mao L;Sun ZJ;Zhang WF
通讯作者:
Zhang WF
DOI:
10.3233/kca-170015
发表时间:
2017-11-27
期刊:
Kidney cancer (Clifton, Va.)
影响因子:
--
作者:
Ghatalia P;Koenigsberg R;Pisarcik D;Handorf EA;Geynisman DM;Zibelman M
通讯作者:
Zibelman M
影响因子:
12.8
作者:
Kim SJ;Yoon S
通讯作者:
Yoon S
影响因子:
4
作者:
Gionet, Nathalie;Jansson, Deidre;Pratt, M. A. Christine
通讯作者:
Pratt, M. A. Christine